Search research articles
Contact Us
Filters
Showing results (271-280 of 333) with videos related to
Page
of 34
Sort By:
British Journal of Cancer
|
September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
C Kollmannsberger, O Rick, H Klaproth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, S Weinknecht, et al.
Der Urologe. Ausg. A
|
July 1, 1998
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]
M A Kuczyk, G Köhn, K Höfner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, J Beyer, R Liersch, et al.
ESMO Open
|
November 10, 2022
Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial
N Harnischfeger, H M Rath, B Alt-Epping, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors
J T Hartmann, C R Nichols, J-P Droz, et al.
Cancer
|
March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumors
S D Fosså, C Bokemeyer, A Gerl, et al.
Oncoimmunology
|
July 2, 2021
Increased frequency of TIGIT<sup>+</sup>CD73-CD8<sup>+</sup> T cells with a TOX<sup>+</sup> TCF-1low profile in patients with newly diagnosed and relapsed AML
F Brauneck, F Haag, R Woost, et al.
Bone Marrow Transplantation
|
April 4, 2000
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
H Einsele, H Hebart, C Kauffmann-Schneider, et al.
Cancer
|
June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
J T Hartmann, C R Nichols, J P Droz, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 333) with videos related to
Sort By:
Page
of 34
British Journal of Cancer
|
September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
C Kollmannsberger, O Rick, H Klaproth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, S Weinknecht, et al.
Der Urologe. Ausg. A
|
July 1, 1998
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]
M A Kuczyk, G Köhn, K Höfner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, J Beyer, R Liersch, et al.
ESMO Open
|
November 10, 2022
Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial
N Harnischfeger, H M Rath, B Alt-Epping, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors
J T Hartmann, C R Nichols, J-P Droz, et al.
Cancer
|
March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumors
S D Fosså, C Bokemeyer, A Gerl, et al.
Oncoimmunology
|
July 2, 2021
Increased frequency of TIGIT<sup>+</sup>CD73-CD8<sup>+</sup> T cells with a TOX<sup>+</sup> TCF-1low profile in patients with newly diagnosed and relapsed AML
F Brauneck, F Haag, R Woost, et al.
Bone Marrow Transplantation
|
April 4, 2000
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
H Einsele, H Hebart, C Kauffmann-Schneider, et al.
Cancer
|
June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
J T Hartmann, C R Nichols, J P Droz, et al.
Page
of 34